Skip to main content

Lisinopril-Hydrochlorothiazide Price: US vs UK

Lisinopril-Hydrochlorothiazide (generic Lisinopril/Hydrochlorothiazide) — average US Medicare Part D spend of $0.0925 per dose (calendar year 2024) vs a flat £9.90 NHS England prescription charge (2026/27 (from 1 April 2026)).

How does the cost of Lisinopril-Hydrochlorothiazide compare in the US and the UK?

In the US, Lisinopril-Hydrochlorothiazide (generic Lisinopril/Hydrochlorothiazide) averaged $0.0925 in Medicare Part D spending per dosage unit in calendar year 2024, over 5,642,341 claims (CMS open data). In England, an NHS patient pays a flat £9.90 per dispensed item (2026/27 (from 1 April 2026)) — the same as for any other drug — or nothing with a Prepayment Certificate or exemption. The US figure is program spend per dose; the UK figure is a patient flat charge. They are not converted. Information only — not medical advice.

Source:CMS Medicare Part D Spending by Drug·as of calendar year 2024updated yearly (last: )

Not medical advice. The figures on this page are drawn unchanged from public government datasets for general information only. They are not price quotes and not a substitute for professional advice. What you actually pay depends on your country, pharmacy, insurance, manufacturer, dose and region. Always consult a licensed pharmacist or clinician before making any decision about Lisinopril/Hydrochlorothiazide or switching medication.

The US figure is Medicare Part D PROGRAM spending per dosage unit (in US dollars), not a cash price; the UK figure is the patient's flat NHS charge per item (in pounds). They measure different things in different currencies and are shown side by side, never converted into one another.

United States

$0.0925

Average Medicare Part D spending per dosage unit, calendar year 2024, over 5.6 million claims. Program spend, not a cash price.

England (NHS)

£9.90

Flat patient charge per item (2026/27 (from 1 April 2026)) — same for any drug; or free with a Prepayment Certificate or exemption.

Lisinopril-Hydrochlorothiazide — the two real figures (CMS, US public domain; NHSBSA/NHS England, OGL v3.0)
MeasureValue
Brand / label nameLisinopril-Hydrochlorothiazide
Generic (active ingredient)Lisinopril/Hydrochlorothiazide
US: avg Medicare Part D spend per dosage unit$0.0925
US reference periodcalendar year 2024
US: total Part D claims (2024)5,642,341
England: NHS patient charge per item£9.90
England: 12-month PPC cap£114.50
UK reference period2026/27 (from 1 April 2026)

In England, an NHS patient pays a flat £9.90 per dispensed prescription item (2026/27 (from 1 April 2026), frozen) — the same charge for any drug, whatever it costs the NHS — or nothing at all with a Prescription Prepayment Certificate (£114.50/year cap, worth it above 11 items/year) or an exemption. NHS prescriptions are free outright in Scotland, Wales and Northern Ireland.

Other common drugs — US vs UK

Frequently asked questions

How much does Lisinopril-Hydrochlorothiazide cost in the US?
CMS reports average Medicare Part D spending of $0.0925 per dosage unit for Lisinopril-Hydrochlorothiazide in calendar year 2024, weighted across all manufacturers over 5,642,341 claims. This is Medicare program spending per billing unit, not a pharmacy cash price.
How much does Lisinopril-Hydrochlorothiazide cost on the NHS in England?
The NHS does not publish a comparable per-drug patient price. What a patient pays is the flat prescription charge: £9.90 per item (2026/27 (from 1 April 2026)), the same for Lisinopril-Hydrochlorothiazide as for any drug — capped by a £114.50/year Prepayment Certificate, free with an exemption, and free outright in Scotland, Wales and Northern Ireland.

Need a prescription for Lisinopril/Hydrochlorothiazide?

A GeraClinic clinician can review your medication, explain lower-cost options where clinically appropriate, and issue or renew a prescription online — without travelling to a clinic.

Contains public sector information published by U.S. Centers for Medicare & Medicaid Services (CMS) and licensed under the U.S. Government Works / Public Domain. Source: CMS Medicare Part D Spending by Drug (calendar year 2024, published 2026-06-25).

Contains public sector information published by NHS Business Services Authority (NHSBSA), NHS England & DHSC and licensed under the Open Government Licence v3.0. Source: NHS prescription charges (England) — NHSBSA / NHS England / DHSC (2026/27 (from 1 April 2026), published 2026-04-01).